Asthma study: KT-621
Official title A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study
ClinicalTrials.gov ID: NCT07677059
What this study is testing
What is KT-621?
This is an investigational oral medicine being studied as a potential treatment for asthma.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether KT‑621 stays safe and works well over a long time in people with asthma.
- Who it's for
- You may be able to join if you had asthma and took KT‑621 in a previous study.
- What's involved
- You will take KT‑621 by mouth at home and have regular check‑ins with the study team. You may also do some simple tests to see how the medicine works in your body.
- Time commitment
- The study lasts many months and includes several visits to the clinic for safety checks and follow‑up.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Must have completed all visits of the parent study, per its protocol, up to the end of treatment (EoT) visit.
- Must be willing and able to comply with scheduled visits, treatment plan, laboratory tests, other study-related procedures, and questionnaires...
- Must agree to contraceptive requirements in compliance with the clinical study and local requirements.
You likely can't join if
- Must not have experienced any clinically significant change in health status during the parent study, which, in the opinion of the Investigator...
- Must not have developed an AE during the parent study, that in the opinion of the Investigator or of the Sponsor's Medical Monitor, could indicate...
- Must not have met permanent discontinuation criteria and/or permanently discontinued study treatment for any reason during the parent study.
- Must not be a member of the Sponsor or site's investigational team or their immediate family.
- Must not be unsuitable to enter the study for any other reason, as judged by the Investigator, including potential risk of noncompliance to study...
The study team makes the final eligibility decision.
Where it is enrolling
- Miami, Florida, United States
- Tampa, Florida, United States
- Dallas, Texas, United States
- Berlin, Germany
- Poznan, Poland
- Kamenitz, Serbia
- Užice, Serbia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Miami, Florida, United States; Tampa, Florida, United States; Dallas, Texas, United States; Berlin, Germany; Poznan, Poland; Kamenitz, Serbia and 1 more location. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.